title: Hypersensitivity reaction to a biosimilar insulin glargine.
authors.affiliation: Department of Endocrinology, Regional Hospital 1st of October, ISSSTE, México, DF, México.
authors.forename: Héctor
authors.initials: H
authors.lastname: García-Nares
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Leyva-Carmona
authors.forename: Neftalí
authors.initials: N
authors.lastname: Pérez-Xochipa
authors.forename: Erwin
authors.initials: E
authors.lastname: Chiquete
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000009:adverse effects*; D008875:Middle Aged; D011379:Prognosis
chemical_list: D059451:Biosimilar Pharmaceuticals; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine